News

In this Leadership Dialogue, I am joined by Brian Pomper, a partner specializing in international trade policy at Akin Gump Strauss Hauer & Feld, and Akin Demehin, vice president of quality and safety policy at the AHA. We discuss tariffs and their potential implications on the health care supply chain.

Food and Drug Administration Commissioner Marty Makary testified May 22 before the Senate Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies on the discretionary budget proposal for fiscal year 2026.

The Administration for Strategic Preparedness and Response May 21 released a bulletin on workplace violence in health care that includes recommendations for strengthening security protocols, enhancing emergency preparedness, supporting workforce mental health and promoting information sharing.

The AHA May 21 voiced support to Senate and House sponsors of the Improving Seniors’ Timely Access to Care Act, legislation that would reduce the variation in prior authorization methods used for Medicare Advantage plans.

The AHA has updated the Stress and Coping Resources website, which contains valuable information and resources t

Jason Lesandrini, Ph.D., assistant vice president of ethics, advanced care planning, spiritual health and language access services at Wellstar Health System, and Kelsey White, Ph.D., assistant prof

The FBI's Internet Crime Complaint Center released an alert May 7 warning of cyber actors exploiting vulnerabilities in end-of-life routers.

Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England Journal of Medicine.

The Department of Health and Human Services today announced it has identified specific pricing targets for pharmaceutical manufacturers to meet to satisfy requirements of the Trump administration’s executive order allowing consumers to make direct purchases from drug manufacturers at “most favored nation” pricing, the lowest cost paid for the same medications in an Organization for Economic Co-operation and Development country with a gross domestic product per capita that is at least 60% of the U.S. GDP per capita.

Secretary of Health and Human Services Robert F. Kennedy Jr. today appeared before the Senate Appropriations Committee for a hearing to testify on the discretionary budget proposal for fiscal year 2026.

A replay of the Hospital Capacity Management Consortium’s Spring Symposium is now available.

The FBI’s Internet Criminal Complaint Center May 15 released an alert warning of a malicious text and voice messaging campaign involving impersonators pretending to be senior U.S. officials.

The Centers for Disease Control and Prevention is assisting in a multistate investigation on the use of contaminated non-sterile ultrasound gel for ultrasound-guided percutaneous procedures.

As Congress weighs significant changes and cuts to Medicaid, the AHA today hosted a Capitol Hill briefing for congressional staff featuring hospital and health system leaders discussing the importance of Medicaid for patients and hospitals.

The House Budget Committee May 18 advanced the fiscal year 2025 budget reconciliation bill by a 17-16 vote along party lines, as four Republicans who previously opposed the bill in a May 16 markup flipped to “present” in yesterday’s tally.

A series of tariffs recently implemented could have significant implications for health care.

The House Budget Committee May 16 voted 21-16 against advancing the fiscal year 2025 budget reconciliation bill, with five Republicans joining all Democrats in voting “no.”

The AHA May 16 urged the Department of Commerce to consid

A U.S. district court judge for the District of Columbia May 15 ruled the Department of Health and Human Services must preapprove the use of 340B “rebate models” before they can be implemented, which the department has not yet done for any of the models pursued by the plaintiff drug companies. 

The Administration for Strategic Preparedness and Response May 15 announced it is launching four pharmaceutical manufacturing projects using artificial intelligence and other technologies in collaboration with the Department of Health and Human Services, the Defense Advanced Research Projects Agency and private sector organizations.